Cargando…
(1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol
The chiral title compound, C(22)H(35)NO(5)SSi, is a precursor of novel furanomycin derivatives. It crystallizes with two molecules in the asymmetric unit; these show different conformations of the silyl substitutent, as indicated by the Si—O—C—C torsion angles of 41.4 (7) and −84.5 (5)° in the two...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961448/ https://www.ncbi.nlm.nih.gov/pubmed/21202678 http://dx.doi.org/10.1107/S1600536808014906 |
_version_ | 1782188985171312640 |
---|---|
author | Erdsack, Jörg Schürmann, Markus Preut, Hans Krause, Norbert |
author_facet | Erdsack, Jörg Schürmann, Markus Preut, Hans Krause, Norbert |
author_sort | Erdsack, Jörg |
collection | PubMed |
description | The chiral title compound, C(22)H(35)NO(5)SSi, is a precursor of novel furanomycin derivatives. It crystallizes with two molecules in the asymmetric unit; these show different conformations of the silyl substitutent, as indicated by the Si—O—C—C torsion angles of 41.4 (7) and −84.5 (5)° in the two molecules. The anti configuration of the adjacent stereogenic centers is consistent with the Felkin–Anh model. Each of the two crystallographically independent molecules is connected with a neighbouring molecule of the same type via two symmetry-equivalent O—H⋯O hydrogen bonds. |
format | Text |
id | pubmed-2961448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-29614482010-12-30 (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol Erdsack, Jörg Schürmann, Markus Preut, Hans Krause, Norbert Acta Crystallogr Sect E Struct Rep Online Organic Papers The chiral title compound, C(22)H(35)NO(5)SSi, is a precursor of novel furanomycin derivatives. It crystallizes with two molecules in the asymmetric unit; these show different conformations of the silyl substitutent, as indicated by the Si—O—C—C torsion angles of 41.4 (7) and −84.5 (5)° in the two molecules. The anti configuration of the adjacent stereogenic centers is consistent with the Felkin–Anh model. Each of the two crystallographically independent molecules is connected with a neighbouring molecule of the same type via two symmetry-equivalent O—H⋯O hydrogen bonds. International Union of Crystallography 2008-05-30 /pmc/articles/PMC2961448/ /pubmed/21202678 http://dx.doi.org/10.1107/S1600536808014906 Text en © Erdsack et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Erdsack, Jörg Schürmann, Markus Preut, Hans Krause, Norbert (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title | (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title_full | (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title_fullStr | (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title_full_unstemmed | (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title_short | (1R,4′S)-4-(tert-Butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
title_sort | (1r,4′s)-4-(tert-butyldimethylsilanoxy)-1-[2,2-dimethyl-3-(p-tolylsulfonyl)-1,3-oxazolidin-4-yl]but-2-yn-1-ol |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961448/ https://www.ncbi.nlm.nih.gov/pubmed/21202678 http://dx.doi.org/10.1107/S1600536808014906 |
work_keys_str_mv | AT erdsackjorg 1r4s4tertbutyldimethylsilanoxy122dimethyl3ptolylsulfonyl13oxazolidin4ylbut2yn1ol AT schurmannmarkus 1r4s4tertbutyldimethylsilanoxy122dimethyl3ptolylsulfonyl13oxazolidin4ylbut2yn1ol AT preuthans 1r4s4tertbutyldimethylsilanoxy122dimethyl3ptolylsulfonyl13oxazolidin4ylbut2yn1ol AT krausenorbert 1r4s4tertbutyldimethylsilanoxy122dimethyl3ptolylsulfonyl13oxazolidin4ylbut2yn1ol |